• About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting
Stock Market Hour
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Stock Market Hour
No Result
View All Result
Home Editor's Pick

Hawley blasts FDA approval of new abortion drug, cites safety and trust concerns

StockMarketHour by StockMarketHour
October 3, 2025
in Editor's Pick
0
Hawley blasts FDA approval of new abortion drug, cites safety and trust concerns
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Sen. Josh Hawley, R-Mo., accused the Food and Drug Administration (FDA) of endangering women’s health, saying the agency approved another chemical abortion drug without the thorough safety review it had promised.

Hawley argued the move shows both regulatory failure and the influence of a company that refuses to define ‘woman’ in its materials.

‘This is shocking. FDA has just approved ANOTHER chemical abortion drug, when the evidence shows chemical abortion drugs are dangerous and even deadly for the mother. And of course 100% lethal to the child,’ he wrote on X on Thursday afternoon.

Hawley added, ‘FDA had promised to do a top-to-bottom safety review of the chemical abortion drug, but instead they’ve just greenlighted new versions of it for distribution. I have lost confidence in the leadership at FDA.’

Evita Solutions describes its mission as to ‘normalize abortion’ and make it ‘accessible to all.’ On its website, the company says it ‘believes that all people should have access to safe, affordable, high-quality, effective, and compassionate abortion care, regardless of their race, sex, gender, age, sexuality, income, or where they live.’

It adds, ‘We know that you can make the best choice for your body.’

According to the FDA, Evita received approval in a Sept. 30 letter obtained by Reuters.

In an interview with Fox News Digital, Hawley said the FDA’s decision was even more troubling given that its promised safety review has barely begun.

‘I just, I can’t figure out what’s happening at the FDA. I’m totally baffled by it,’ Hawley said.

Fox News Digital has reached out to the FDA and Evita Solutions for comment on the matter.

In another post, Hawley blasted the FDA for partnering with a company that ‘doesn’t even believe there is such a thing as a ‘woman.’’

Evita Solutions now joins GenBioPro in producing the generic version of Mifepristone, the abortion pill originally made by Danco Laboratories. Mifepristone blocks progesterone, a hormone needed to sustain pregnancy, and is followed by misoprostol to complete the process.

The approval comes as abortion drugs face mounting opposition from conservative lawmakers, religious organizations, and pro-life groups.

Religious groups like Inspire Investing and Alliance Defending Freedom have campaigned against the drug, while the Restoration of America Foundation (ROAF) has pressed lawmakers for accountability.

Last month, ROAF called on the Senate Finance Committee to hold Health and Human Services Secretary Robert F. Kennedy Jr. accountable at a hearing, demanding answers about the removal of safety protocols for the abortion pill Mifepristone.

In a letter obtained by Fox News Digital, ROAF warned that the rollback leaves women more vulnerable and shifts costs to taxpayers. The group said the Biden-era changes endanger women by allowing abortion pills to be prescribed via telehealth and sent through the mail.

Hawley said the FDA should restore the safeguards put in place under the Trump administration.

‘What needs to happen is the FDA needs to get in line with the president’s policy and put back into place the safety regulations President Trump had. Ditch the Biden approach and go back to President Trump’s approach,’ Hawley said.

Under the Biden administration, the FDA for the first time allowed telehealth prescribing and mail-order delivery of abortion pills. Previously, the agency required Mifepristone to be dispensed in person to screen for complications such as ectopic pregnancy.

Fox News Digital’s Jasmine Baehr and Reuters contributed to this report.

This post appeared first on FOX NEWS

Previous Post

Federal judge to sentence Justice Brett Kavanaugh’s attempted assassin

Next Post

Locksley Advances Multiple Antimony & REE Workstreams

StockMarketHour

StockMarketHour

Next Post
Locksley Advances Multiple Antimony & REE Workstreams

Locksley Advances Multiple Antimony & REE Workstreams

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Iranian Rapper Toomaj Salehi Faces Death Sentence for Speaking Out

Iranian Rapper Toomaj Salehi Faces Death Sentence for Speaking Out

May 6, 2024
‘Fox News Delivers Shocking Blow to Republicans’ case against Biden!’

‘Fox News Delivers Shocking Blow to Republicans’ case against Biden!’

September 26, 2023
CHARBONE Powers Up: Ready to Debut First Green Hydrogen Facility & Secures Offer for Hydro Project Assets

CHARBONE Powers Up: Ready to Debut First Green Hydrogen Facility & Secures Offer for Hydro Project Assets

May 2, 2024
Tesla’s Supercharger Team Slashed by Musk: What’s in Store for America’s EV Network?

Tesla’s Supercharger Team Slashed by Musk: What’s in Store for America’s EV Network?

May 6, 2024
Locksley Resources LimitedAdvances Multiple Antimony and REE Workstreams

Locksley Resources LimitedAdvances Multiple Antimony and REE Workstreams

0
“2,000 Workers Sent Home: General Motors Plant Goes Idle as Strike Intensifies

“2,000 Workers Sent Home: General Motors Plant Goes Idle as Strike Intensifies

0
“The Lofty Price of Olive Oil: Record Highs Spark Cooking Oil Thefts

“The Lofty Price of Olive Oil: Record Highs Spark Cooking Oil Thefts

0
“Joint Chiefs Chair Confirmed Despite Tuberville Blockade: Senate Breathes Sigh of Relief!

“Joint Chiefs Chair Confirmed Despite Tuberville Blockade: Senate Breathes Sigh of Relief!

0
Locksley Resources LimitedAdvances Multiple Antimony and REE Workstreams

Locksley Resources LimitedAdvances Multiple Antimony and REE Workstreams

October 3, 2025
UPS Batteries For Explosive (EX & ATEX) Environments

UPS Batteries For Explosive (EX & ATEX) Environments

October 3, 2025
Locksley Advances Multiple Antimony & REE Workstreams

Locksley Advances Multiple Antimony & REE Workstreams

October 3, 2025
Reagan-appointed judge, once rebuked by Supreme Court, continues to lambaste Trump

Reagan-appointed judge, once rebuked by Supreme Court, continues to lambaste Trump

October 3, 2025

Recent News

Locksley Resources LimitedAdvances Multiple Antimony and REE Workstreams

Locksley Resources LimitedAdvances Multiple Antimony and REE Workstreams

October 3, 2025
UPS Batteries For Explosive (EX & ATEX) Environments

UPS Batteries For Explosive (EX & ATEX) Environments

October 3, 2025
Locksley Advances Multiple Antimony & REE Workstreams

Locksley Advances Multiple Antimony & REE Workstreams

October 3, 2025
Reagan-appointed judge, once rebuked by Supreme Court, continues to lambaste Trump

Reagan-appointed judge, once rebuked by Supreme Court, continues to lambaste Trump

October 3, 2025

Disclaimer: StockMarketHour.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Copyright © 2025 StockMarketHour. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 StockMarketHour. All Rights Reserved.